Companies Cryptocurrencies
Spectrum Pharmaceuticals Inc
Spectrum Pharmaceuticals Inc
Exchange: Nasdaq Global Select
IPO Date: 26/09/1996
CEO: Mr. Joseph Turgeon
Biotechnology Healthcare 🔗
  • SPPI
  • 0.8117
  • 146176624
    market cap
  • 0.04210001
If you bought

shares of Spectrum Pharmaceuticals Inc (SPPI) on
You would have made
Old Price $12 Current Price $12

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. The company is headquartered in Henderson, Nevada and currently employs 235 full-time employees. The firm operates through developing and commercializing oncology and hematology drug products segment. The company focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.

Address: 11500 S Eastern Ave Ste 240 Henderson NEVADA 89052

Stay updated.